The risk of serious bacterial infection in patients in primary care without clear clinical danger signs is low, and the majority of patients in the trial had low CRP concentrations on day 0 (<20 mg/L in 72% of patients and <40 mg/L in 86%; appendix). The gene discussed is CRP; the disease is bacterial infectious disease.